Last reviewed · How we verify

NCT04036604

Investigation of The Effect of Pelvic Floor Exercise Programme in Elderly.

Completed NA Last updated 31 July 2019
What this trial tests

NA trial testing Exercise in Pelvic Floor Muscle Weakness in 94 participants. Completed in 2 June 2019.

Timeline
21 January 2019
Primary endpoint
30 May 2019
2 June 2019

Quick facts

Lead sponsorAkdeniz University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment94
Start date21 January 2019
Primary completion30 May 2019
Estimated completion2 June 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Akdeniz University

Who can join

Adults 65 to 75, any sex, with Pelvic Floor Muscle Weakness or Urinary Incontinence in Old Age. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Alteration of hormonal structure and decreasing of muscle tissue with aging causes pelvic floor dysfunction. Over age of 65 so many factors such as decrease in volume of muscle tissue, decrease in the amount of estrogen / testosterone, and low level of physical activity cause problems such as incontinence, prolapse, constipation and sexual dysfunction The aim of this study is to investigate the effectiveness of pelvic floor exercise program on sexual dysfunction, incontinence, quality of life and physical activity level in elderly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Pelvic Floor Muscle Weakness

Currently open trials in the same condition.

Other Akdeniz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04036604.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing